Enzastaurin
AR101-PREVEnt
Phase 3 small_molecule on_hold
Quick answer
Enzastaurin for Vascular Ehlers-Danlos Syndrome is a Phase 3 program (small_molecule) at AYTU BIOPHARMA, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AYTU BIOPHARMA, INC
- Indication
- Vascular Ehlers-Danlos Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- on_hold